ClinicalTrials.Veeva

Menu

Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma (TRANSCLERO)

U

University Hospital Center (CHU) Dijon Bourgogne

Status

Enrolling

Conditions

Scleroderma

Treatments

Procedure: Skin samples
Other: Analysis of fibroblasts

Study type

Observational

Funder types

Other

Identifiers

NCT07256418
BONNOTTE 2025-2

Details and patient eligibility

About

Scleroderma is a complex connective tissue disease involving three interconnected pathophysiological axes: vascular hyperactivity and remodelling, immune system dysfunction and over-activation of fibroblasts at the origin of the fibrosis process in the skin and organs. Given that this pathology occurs preferentially in mature subjects, it is possible to suggest a potential inductive role for senescent fibroblasts, which would be responsible for activating and/or maintaining the immune response and systemic inflammation. Our hypothesis is that fibroblasts play a predominant role in the genesis and maintenance of this pathology.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

FOR PATIENTS WITH SCLERODERMA :

  • Person who has given written consent
  • Person with systemic scleroderma

FOR CONTROL PARTICIPANTS :

  • Person who has given written consent
  • Person undergoing plastic, cosmetic and reconstructive surgery

Exclusion criteria

FOR PATIENTS WITH SCLERODERMA :

  • Person not affiliated to or not benefiting from a social security scheme
  • Person subject to a legal protection measure (curatorship, guardianship)
  • Person subject to a legal protection measure
  • An adult who is incapable or unable to give consent
  • Minors

FOR CONTROLLED PARTICIPANTS :

  • Person suffering from a chronic disease or under chronic treatment for autoimmune, inflammatory or dermatological diseases
  • Person not affiliated to or not benefiting from a social security scheme
  • Person under legal protection (curatorship, guardianship)
  • Person subject to a legal protection measure
  • An adult who is incapable or unable to give consent
  • Minors

Trial design

60 participants in 2 patient groups

scleroderma
Description:
People with systemic scleroderma
Treatment:
Other: Analysis of fibroblasts
Procedure: Skin samples
Control
Description:
People undergoing plastic, cosmetic and reconstructive surgery
Treatment:
Other: Analysis of fibroblasts
Procedure: Skin samples

Trial contacts and locations

1

Loading...

Central trial contact

Bernard BONNOTTE

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems